Figure 1.
Biomarker values according to left ventricular ejection fraction. Comparison of galectin-3 (A), sST2 (B), and NT-proBNP (C) between HFpEF, HFrEF, and controls. Soluble suppression of tumorigenicity-2 (sST2), N-terminal pro-B-type natriuretic peptide (NT-proBNP). * P<0.05 vs. Control, # P<0.05 vs. HFpEF.
